歡迎光臨源葉生物,登錄 | 注冊 |
當前位置: 首頁 > 小分子抑制劑 > GPCR/GProtein > BMS-986020

瀏覽歷史

S82609

BMS-986020

源葉(MedMol) ≥99%
  • 英文名:
  • BMS-986020
  • 別名:
  • 1-{4'-[3-methyl-4-((R)-1-phenyl-ethoxycarbonylamino)-isoxazol-5-yl]-biphenyl-4-yl}-cyclopropanecarboxylic acid; (R)-1-(4'-(3-methyl-4-((1-phenylethoxy)carbonylamino)isoxazol-5-yl)biphenyl-4-yl)cyclopr
  • CAS號:
  • 1257213-50-5
  • 分子式:
  • C29H26N2O5
  • 分子量:
  • 482.5271
  • 核磁/質譜:
品牌貨號產品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數量計量單位 加入購物車...
源葉(MedMol) S82609-5mg ≥99% ¥336.00元 10 - - - EA 加入購物車
源葉(MedMol) S82609-10mg ≥99% ¥593.00元 10 - - - EA 加入購物車
源葉(MedMol) S82609-25mg ≥99% ¥1261.00元 8 - - - EA 加入購物車
源葉(MedMol) S82609-50mg ≥99% ¥2144.00元 6 - - - EA 加入購物車
源葉(MedMol) S82609-100mg ≥99% ¥3645.00元 4 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權與保護申明》,到貨后將短信提示。
提交

產品介紹

參考文獻

質檢證書(COA)

摩爾濃度計算器

相關產品

  • 提示:詳情請下載說明書。
  • 產品描述: BMS-986020 (AM152, AP-3152 free acid) 是一種有效的 lysophosphatidic acid receptor 1 (LPA1) 的選擇性拮抗劑。BMS-986020 可抑制膽汁酸和磷脂轉運蛋白,對于BSEP、MRP4和MDR3的IC50值分別為4.8 μM、6.2 μM和7.5 μM。BMS-986020 具有治療特發(fā)性肺纖維化 idiopathic pulmonary fibrosis (IPF) 的潛力
  • 靶點: LPA1; BSEP(Cell-free assay): 4.8 μM; MRP4(Cell-free assay):6.2 μM; MDR3(Cell-free assay):7.5 μM;LPAReceptor;?LPLReceptor
  • 體外研究:
    BMS-986020, a selective and potent lysophosphatidic acid receptor 1 (LPA1) inhibitor, inhibits LPA1-induced fibrogenesis in the Scar-in-a-Jar in vitro model
  • 細胞實驗: Cell lines: Human lung fibroblasts Concentrations: 12 days Incubation Time: 0.01, 0.05, 0.1, 0.5, 1, or 5 μM Method: Human lung fibroblasts were cultured in 48-well plates in Dulbecco’s Modified Eagle Medium (DMEM)?+?GlutaMax with 0.4% fetal bovine serum, 37.5 mg/mL Ficoll 70, 25 mg/mL Ficoll 400, and 1% ascorbic acid. Cells were stimulated with 1 ng/mL transforming growth factor beta 1 (TGF-β1) or 20 μM LPA with or without BMS-986020 (0.01, 0.05, 0.1, 0.5, 1, or 5 μM) diluted in dimethyl sulfoxide (DMSO), or vehicle (0.05% DMSO) in four replicates. Cells were cultured at 37 °C with 95% O2 and 5% CO2 for 12 days, and medium was changed at Day 4 and 8. Supernatants were stored at ???20 °C until biomarker measurements. alamarBlue was used to quantify cellular metabolism at Day 0 (prior to drug treatment) and Day 12. Release of lactate dehydrogenase (LDH) was quantified at Day 4, 8, and 12.
  • 參考文獻:
    1. Glenn Rosen, et al. LPA1 antagonists BMS-986020 and BMS-986234 for idiopathic pulmonary fibrosis: Preclinical evaluation of hepatobiliary homeostasis. European Respiratory Journal 2017 50: PA1038; vol. 50 no. suppl 61. 2. Decato BE, et al. LPA1 antagonist BMS-986020 changes collagen dynamics and exerts antifibrotic effects in vitro and in patients with idiopathic pulmonary fibrosis. Respir Res. 2022 Mar 18;23(1):61.
  • 溶解性: Soluble  in  DMSO、Ethanol
  • 保存條件: -20°C
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.072 ml 10.362 ml 20.724 ml
    5 mM 0.414 ml 2.072 ml 4.145 ml
    10 mM 0.207 ml 1.036 ml 2.072 ml
    50 mM 0.041 ml 0.207 ml 0.414 ml
  • 注意:部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。
輸入產品批號:

本計算器可幫助您計算出特定溶液中溶質的質量、溶液濃度和體積之間的關系,公式為:


質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產品僅用作科學研究,銷售產品行為均適用于我司網上所列通用銷售條款。